| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 70 | 98 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -70 | -98 | -2 | -2 | -2 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -70 | -98 | -2 | -2 | -2 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ait Laboratories S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.280 | 2.158 | 2.120 | 2.079 | 608 | 596 | 583 | 585 | 487 | 484 |
| Inventories | 152 | 150 | 148 | 145 | 142 | 140 | 136 | 137 | 0 | 0 |
| Receivables | 1.857 | 1.838 | 1.807 | 1.774 | 304 | 298 | 291 | 292 | 487 | 484 |
| Cash | 271 | 170 | 165 | 161 | 162 | 159 | 155 | 156 | 0 | 0 |
| Shareholders Funds | 2.256 | 2.134 | 2.096 | 2.056 | 585 | 574 | 561 | 563 | 487 | 484 |
| Social Capital | 900 | 891 | 876 | 860 | 843 | 827 | 809 | 811 | 809 | 804 |
| Debts | 24 | 24 | 24 | 23 | 23 | 22 | 22 | 22 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5811 - 5811" | |||||||||
| CAEN Financial Year |
5811
|
|||||||||
Comments - Ait Laboratories S.r.l.